Search Results - "Pledger, W. Jack"
-
1
Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant APC and TP53 Subpopulations
Published in Cancer epidemiology, biomarkers & prevention (01-07-2019)“…EGFR is a major therapeutic target for colorectal cancer. Currently, extended testing identifies only nonresponders to EGFR inhibitors (EGFRi). We aimed to…”
Get full text
Journal Article -
2
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy
Published in BMC cancer (10-03-2022)“…Over half of colorectal cancers (CRCs) are hard-wired to RAS/RAF/MEK/ERK pathway oncogenic signaling. However, the promise of targeted therapeutic inhibitors,…”
Get full text
Journal Article -
3
MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
Published in The Journal of biological chemistry (22-05-2009)“…Members of the FOXO (forkhead O) class of transcription factors are tumor suppressors that also control aging and organismal life span. Mammalian FOXO…”
Get full text
Journal Article -
4
Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on src kinase for survival
Published in Cancer research (Chicago, Ill.) (15-03-2007)“…Sarcomas are rare malignant mesenchymal tumors for which there are limited treatment options. One potential molecular target for sarcoma treatment is the Src…”
Get full text
Journal Article -
5
Proliferative status regulates HDAC11 mRNA abundance in nontransformed fibroblasts
Published in Cell cycle (Georgetown, Tex.) (01-11-2013)“…Histone deacetylases (HDACs) are important determinants of gene transcription and other biological processes. HDAC11 is one of the least characterized HDACs…”
Get full text
Journal Article -
6
Identification of Aurora-A as a Direct Target of E2F3 during G2/M Cell Cycle Progression
Published in The Journal of biological chemistry (07-11-2008)“…Aurora-A is a centrosome kinase and plays a pivotal role in G2/M cell cycle progression. Expression of Aurora-A is cell cycle-dependent. Levels of Aurora-A…”
Get full text
Journal Article -
7
Roscovitine Inhibits Differentiation and Invasion in a Three-Dimensional Skin Reconstruction Model of Metastatic Melanoma
Published in Molecular cancer research (01-02-2007)“…The aim of this study was to investigate the therapeutic potential of a cyclin-dependent kinase inhibitor, roscovitine, in cultured melanoma cells and a…”
Get full text
Journal Article -
8
The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability
Published in Aging (Albany, NY.) (15-11-2022)“…Cyclin F, unlike canonical and transcriptional cyclins, does not bind or activate any cyclin-dependent kinases. Instead, it harbors an F-box motif and…”
Get full text
Journal Article -
9
Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis
Published in Nature cell biology (01-10-2007)“…Autophagy is an evolutionarily conserved 'self-eating' process. Although the genes essential for autophagy (named Atg) have been identified in yeast, the…”
Get full text
Journal Article -
10
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation
Published in Scientific reports (18-06-2018)“…Colorectal cancer (CRC) growth and progression is frequently driven by RAS pathway activation through upstream growth factor receptor activation or through…”
Get full text
Journal Article -
11
PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
Published in Oncotarget (26-11-2019)“…PTPRS is the most commonly mutated receptor tyrosine phosphatase in colorectal cancer (CRC). PTPRS has been shown to directly affect ERK and regulate its…”
Get full text
Journal Article -
12
Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression
Published in The Journal of biological chemistry (21-10-2016)Get full text
Journal Article -
13
Assessing needs and assets for building a regional network infrastructure to reduce cancer related health disparities
Published in Evaluation and program planning (01-06-2014)“…•We detail the efforts behind the development of the Region 3 GMaP/BMaP network.•The network is comprised of over 100 investigators from nine institutions.•We…”
Get full text
Journal Article -
14
Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model
Published in Oncogene (09-11-2000)“…Upregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 and subsequent cell growth arrest or senescence is one mechanism by which normal cells are…”
Get full text
Journal Article -
15
Loss of nuclear p21(Cip1/WAF1) during neoplastic progression to metastasis in gamma-irradiated p21 hemizygous mice
Published in Experimental and molecular pathology (01-06-2007)“…p21(Cip1/WAF1) localizes to the nucleus in response to gamma-irradiation induced DNA damage and mediates a G(1) checkpoint arrest. Although gamma-irradiated…”
Get full text
Journal Article -
16
Loss of nuclear p21Cip1/WAF1 during neoplastic progression to metastasis in γ-irradiated p21 hemizygous mice
Published in Experimental and molecular pathology (01-06-2007)“…p21 Cip1 / WAF1 localizes to the nucleus in response to γ-irradiation induced DNA damage and mediates a G 1 checkpoint arrest. Although γ-irradiated p21 +/-…”
Get full text
Journal Article -
17
p21Cip1 nullizygosity increases tumor metastasis in irradiated mice
Published in Cancer research (Chicago, Ill.) (15-06-2003)“…p21(Cip1) is a cyclin-dependent kinase inhibitor whose abundance increases in cells exposed to radiation or other DNA-damaging agents. Such increases activate…”
Get full text
Journal Article -
18
Activation of p27Kip1 Expression by E2F1
Published in The Journal of biological chemistry (01-04-2005)“…The E2F1 transcription factor is a critical regulator of cell cycle due to its ability to promote S phase entry. However, E2F1 overexpression also sensitizes…”
Get full text
Journal Article -
19
Abstract 5789: A novel role of APC-partnering mutations in the sidedness of colorectal cancer survival
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Left-sided colorectal cancer (CRC) tumors have been reported to be more favorably associated with better survival than right-sided tumors. A molecular…”
Get full text
Journal Article -
20
Abstract 1083: A novel role of SRC in mediating bypass resistance to MEK inhibition in colorectal cancer stem cells
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Colorectal cancers (CRCs) are hard-wired to RAS/RAF/MEK/ERK pathway oncogenic signaling. However, the promise of targeted therapeutic inhibitors…”
Get full text
Journal Article